GBI Biomanufacturing

GBI (formerly Goodwin Biotechnology), based in Florida, USA, brings 30 years of experience in recombinant protein, antibody, bioconjugate and exosome manufacturing, working with more than 150 clients on nearly 500 different products across Phase I-III and helping file more than 45 INDs. The company is expanding capacity to support upcoming commercial programs, offering in-house capabilities spanning drug substance through drug product under one roof.